...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

Is Don responsible for anything?  It  often doesnt seem that way.  I am hopeful  when either Zenith or RVX or both get a deal that he invests some of his money in a calendar/timetable or a watch. 

Share
New Message
Please login to post a reply